Vivo Ventures V, Llc - Net Worth and Insider Trading

Vivo Ventures V, Llc Net Worth

The estimated net worth of Vivo Ventures V, Llc is at least $942,335 dollars as of 2024-08-25. Vivo Ventures V, Llc is the 10% Owner of Sagent Pharmaceuticals Inc and owns about 41,980 shares of Sagent Pharmaceuticals Inc (SGNT) stock worth over $913,485. Vivo Ventures V, Llc is also the 10% Owner of MEI Pharma Inc and owns about 9,188 shares of MEI Pharma Inc (MEIP) stock worth over $28,850. Details can be seen in Vivo Ventures V, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Vivo Ventures V, Llc has not made any transactions after 2015-11-09 and currently still holds the listed stock(s).

Transaction Summary of Vivo Ventures V, Llc

To

Vivo Ventures V, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vivo Ventures V, Llc owns 4 companies in total, including Soleno Therapeutics Inc (SLNO) , Sagent Pharmaceuticals Inc (SGNT) , and MEI Pharma Inc (MEIP) among others .

Click here to see the complete history of Vivo Ventures V, Llc’s form 4 insider trades.

Insider Ownership Summary of Vivo Ventures V, Llc

Ticker Comapny Transaction Date Type of Owner
SLNO Soleno Therapeutics Inc 2015-08-12 10 percent owner
SGNT Sagent Pharmaceuticals Inc 2016-08-29 10 percent owner
MEIP MEI Pharma Inc 2015-11-09 10 percent owner
LIMIT LIMIT 2007-05-10 10 percent owner

Vivo Ventures V, Llc Latest Holdings Summary

Vivo Ventures V, Llc currently owns a total of 2 stocks. Among these stocks, Vivo Ventures V, Llc owns 41,980 shares of Sagent Pharmaceuticals Inc (SGNT) as of September 16, 2013, with a value of $913,485 and a weighting of 96.94%. Vivo Ventures V, Llc also owns 9,188 shares of MEI Pharma Inc (MEIP) as of November 9, 2015, with a value of $28,850 and a weighting of 3.06%.

Latest Holdings of Vivo Ventures V, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SGNT Sagent Pharmaceuticals Inc 2013-09-16 41,980 21.76 913,485
MEIP MEI Pharma Inc 2015-11-09 9,188 3.14 28,850

Holding Weightings of Vivo Ventures V, Llc


Vivo Ventures V, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Vivo Ventures V, Llc has made a total of 0 transactions in Sagent Pharmaceuticals Inc (SGNT) over the past 5 years. The most-recent trade in Sagent Pharmaceuticals Inc is the sale of 539,017 shares on September 16, 2013, which brought Vivo Ventures V, Llc around $11 Million.

According to the SEC Form 4 filings, Vivo Ventures V, Llc has made a total of 0 transactions in MEI Pharma Inc (MEIP) over the past 5 years. The most-recent trade in MEI Pharma Inc is the sale of 1,135 shares on November 9, 2015, which brought Vivo Ventures V, Llc around $41,755.

Insider Trading History of Vivo Ventures V, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Vivo Ventures V, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Vivo Ventures V, Llc Ownership Network

Ownership Network List of Vivo Ventures V, Llc

No Data

Ownership Network Relation of Vivo Ventures V, Llc

Insider Network Chart

Vivo Ventures V, Llc Owned Company Details

What does Soleno Therapeutics Inc do?

Who are the key executives at Soleno Therapeutics Inc?

Vivo Ventures V, Llc is the 10 percent owner of Soleno Therapeutics Inc. Other key executives at Soleno Therapeutics Inc include Chief Financial Officer James H Mackaness , See Remarks Patricia C Hirano , and See Remarks Kristen Yen .

Soleno Therapeutics Inc (SLNO) Insider Trades Summary

Over the past 18 months, Vivo Ventures V, Llc made no insider transaction in Soleno Therapeutics Inc (SLNO). Other recent insider transactions involving Soleno Therapeutics Inc (SLNO) include a net sale of 342,736 shares made by Bhatnagar Anish , a net sale of 65,201 shares made by Kristen Yen , and a net sale of 33,677 shares made by Patricia C Hirano .

In summary, during the past 3 months, insiders sold 195,096 shares of Soleno Therapeutics Inc (SLNO) in total and bought 0 shares, with a net sale of 195,096 shares. During the past 18 months, 1,614,953 shares of Soleno Therapeutics Inc (SLNO) were sold and 1,210,087 shares were bought by its insiders, resulting in a net sale of 404,866 shares.

Soleno Therapeutics Inc (SLNO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Soleno Therapeutics Inc Insider Transactions

No Available Data

Vivo Ventures V, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Vivo Ventures V, Llc. You might contact Vivo Ventures V, Llc via mailing address: 505 Hamilton Avenue, Suite 200, Palo Alto Ca 94301.

Discussions on Vivo Ventures V, Llc

No discussions yet.